Relaxin: antifibrotic properties and effects in models of disease
about
Novel insights into the bovine polled phenotype and horn ontogenesis in BovidaeCandidate genes controlling pulmonary function in mice: transcript profiling and predicted protein structure.Identification of retinoic acid in a high content screen for agents that overcome the anti-myogenic effect of TGF-beta-1.Relaxin regulates MMP expression and promotes satellite cell mobilization during muscle healing in both young and aged mice.Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-β/Smad3 signaling.Relaxin regulates vascular wall remodeling and passive mechanical properties in mice.The minimal active structure of human relaxin-2Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of SerelaxinThe emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.Relaxin improves multiple markers of wound healing and ameliorates the disturbed healing pattern of genetically diabetic mice.Human relaxin-2: historical perspectives and role in cancer biology.The Role of Relaxin in Normal and Abnormal Uterine Function During the Menstrual Cycle and Early Pregnancy.Relaxin signaling activates peroxisome proliferator-activated receptor gamma.Human relaxin gene expression delivered by bioreducible dendrimer polymer for post-infarct cardiac remodeling in rats.Combination therapy with relaxin and methylprednisolone augments the effects of either treatment alone in inhibiting subepithelial fibrosis in an experimental model of allergic airways disease.Identification of recombinant human relaxin-2 in equine plasma by liquid chromatography-high resolution mass spectrometry.Effect of relaxin on TGF-beta1 expression in cultured vaginal fibroblasts from women with stress urinary incontinence.The effect of pregnancy on hiatal dimensions and urethral mobility: an observational study.Differences in the renal antifibrotic cGMP/cGKI-dependent signaling of serelaxin, zaprinast, and their combination.Umbilical Hernia Repair and Pregnancy: Before, during, after….Presence of relaxin-2, oxytocin and their receptors in uterosacral ligaments of pre-menopausal patients with and without pelvic organ prolapse.Gene duplication and positive selection explains unusual physiological roles of the relaxin gene in the European rabbit.Relaxin does not rescue coronal suture fusion in craniosynostotic rabbits
P2860
Q21090752-5A7B8F2A-680C-4534-A438-9AF955D33B98Q30364215-B13BC887-F865-4B12-BD29-2C410152AC65Q33770085-93082DF8-74E9-4D3B-829E-4FE99E5B20C4Q34254473-EE37C334-0BC7-4E9F-A54E-C977C23A0211Q34737733-D43B50F2-A86B-4B0D-8284-5D1C70FD4C57Q35108756-DBFE84B1-ED18-4D58-9E06-5B43690D5F40Q35423895-6D015757-084E-4DBF-81D6-D7EDF0C276CAQ37083919-E3D2D555-5546-45E0-A1FF-64786BF02D92Q37147122-F02DF310-0B35-46D0-8FEA-87FA3254527EQ37532442-5CEC735E-A51E-4F8C-B9AD-9571A5C05A57Q38031427-97395EE3-4F59-44D0-B8AC-B4B5CFA02073Q38882840-4CF2B511-783F-40F4-808F-1B45FBD5D099Q39807254-E3EA2D33-3341-4338-BFEA-712125B5676FQ41762985-A71E8EAA-6799-486D-9C2B-688C2A2BE360Q43719593-96AC32D8-559E-49DC-95F5-6403A1BA4A45Q45718465-A77AD1A5-6539-4459-AEF8-7146E0D25C7CQ46644999-AF52A7D6-C03F-42BB-B043-894D1DC7149EQ47765449-80D57458-11D7-4E73-91E7-0101DAFC9A48Q48205666-A40591F2-3EAB-4668-9EEB-144BBE27470DQ50045687-466E267D-D8B0-4CA7-BC72-DD1E7B60077EQ50654047-0791F723-BDBA-4130-B025-4A2AC1003F27Q51418822-01202897-02EA-4A22-B49F-6448DC75B161Q56320820-E32AC7F7-D0CE-4CAE-ACF2-9C077F5D5939
P2860
Relaxin: antifibrotic properties and effects in models of disease
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Relaxin: antifibrotic properties and effects in models of disease
@ast
Relaxin: antifibrotic properties and effects in models of disease
@en
Relaxin: antifibrotic properties and effects in models of disease
@nl
type
label
Relaxin: antifibrotic properties and effects in models of disease
@ast
Relaxin: antifibrotic properties and effects in models of disease
@en
Relaxin: antifibrotic properties and effects in models of disease
@nl
prefLabel
Relaxin: antifibrotic properties and effects in models of disease
@ast
Relaxin: antifibrotic properties and effects in models of disease
@en
Relaxin: antifibrotic properties and effects in models of disease
@nl
P2860
P356
P1476
Relaxin: antifibrotic properties and effects in models of disease
@en
P2093
Chrishan S Samuel
P2860
P304
P356
10.3121/CMR.3.4.241
P577
2005-11-01T00:00:00Z